FIHL Fidelis Insurance Holdings Limited

Fidelis Insurance (NYSE:FIHL) reached a new 52-week high of $19.83 during Monday trading. The company has mixed fundamentals, with slightly beating EPS estimates but missing revenue, and analysts are divided on its outlook, with a consensus "Hold" rating and a price target of $21.14. Fidelis Insurance also declared a quarterly dividend of $0.15 per share.

Fidelis Insurance Holdings Ltd (FIHL) stock hit a new 52-week high at $19.83, reflecting an 11.41% increase over the past year and a 22.3% return in the last six months. The company reported strong Q3 2025 results with EPS of $1.24 and revenue of $797.5 million, exceeding expectations. Analyst ratings are mixed, with Goldman Sachs maintaining a Sell rating while Keefe, Bruyette & Woods has an Outperform rating despite adjusting price targets.

Fidelis Insurance Holdings Ltd (FIHL) stock has hit a new 52-week high of $19.83, reflecting an 11.41% increase over the past year and 22.3% over six months. This surge follows strong Q3 2025 financial results, with EPS of $1.24 and revenue of $797.5 million, surpassing expectations. Analysts at Goldman Sachs and Keefe, Bruyette & Woods have adjusted price targets, indicating mixed but significant attention to FIHL's performance.

Fidelis Insurance Holdings (NYSE:FIHL) is gaining market momentum due to rapid net premium expansion and strong revenue growth forecasts, with its share price having seen an 8.96% return over 90 days and 10.25% over one year. The company is currently trading at $19.21, which analysts suggest is undervalued compared to a narrative-driven fair value of $20.67, despite potential risks from catastrophe-heavy lines and rising regulatory pressures. Investors are prompted to question if the market has fully priced in this anticipated growth.

Fidelis Insurance Holdings (NYSE:FIHL) is experiencing rapid premium expansion and solid revenue growth, reinforced by market share gains. Despite an 8.96% 90-day share price return, the company is still considered 7% undervalued by analysts, with a narrative fair value near $20.67 against its current $19.21. However, potential risks like concentrated exposure to catastrophe-heavy lines and rising regulatory pressures could challenge this bullish outlook.

Wall Street Zen has upgraded Fidelis Insurance (NYSE:FIHL) from "hold" to "buy," despite a mixed Street consensus of "Hold" with an average target price of $21.14. The company, with a $2.12 billion market cap, recently reported $1.21 EPS (beating estimates) but missed revenue expectations, showing slight negative net margins and ROE. Institutional investors hold approximately 81.99% of the stock, with significant stake increases from firms like Cooperman, JPMorgan, and Creative Planning.